CTRI/2018/04/012920
Recruiting
未知
A prospective observational clinical trial with case control study design to test the prognostic ability of a proprietary OncoDiscoverTM diagnostic technology designed to capture and concentrate circulating tumor cells (CTCs) in blood samples of patients with various carcinomas and its use to predict progression free survival (PFS) and disease free survival (DFS). (PROGCTC)
Actorius Innovations and Research Pvt Ltd0 sites0 target enrollmentTBD
Overview
- Phase
- 未知
- Intervention
- Not specified
- Conditions
- Health Condition 1: null- Quasi-metastatic patients (stage II & stage III) suffering from the breast, colo-rectal, cervical, ovarian, esophageal / stomach and loco-regional (oral, larynx, tongue, head & neck etc.) cancers
- Sponsor
- Actorius Innovations and Research Pvt Ltd
- Status
- Recruiting
- Last Updated
- 4 years ago
Overview
Brief Summary
No summary available.
Investigators
Eligibility Criteria
Inclusion Criteria
- •1\. Quasi\-metastatic patients (stage II \& stage III) suffering from the breast, colo\-rectal, cervical, ovarian, esophageal / stomach and loco\-regional (oral, larynx, tongue, head \& neck etc.) cancers would be considered for the aforementioned trial.
- •2\. Males (lung, colorectal, esophageal, stomach, loco\-regional) and/or females (Breast, ovarian, cervical, colorectal, esophageal, stomach, loco\-regional).
- •3\. Patients who are yet to receive the treatment.
- •4\. Age \> 18 years.
- •5\. Patients who are well counselled about the trial and from who written informed consent obtained.
- •6\. Confirmed diagnosis of Stage II or III cancer by oncologist.
- •7\. Able to undergo blood collection after diagnosis and prior to surgery and initiation of the therapy,
- •8\. Those patients, who would provide the blood sample after diagnosis, surgery and at the initiation, in the course of and at the end of the treatment.
Exclusion Criteria
- •1\. Patients unable to understand the research protocol and/or provide informed consent.
- •2\. Patients with known immunodeficiency, or pregnancy.
- •3\. Participation in another cancer screening trial.
Outcomes
Primary Outcomes
Not specified
Similar Trials
Not yet recruiting
Phase 4
comparing the effectiveness between 2 ureteral stents- 5Fr vs 6FrHealth Condition 1: N201- Calculus of ureterCTRI/2023/11/059605Dr Nisanth Puliyath
Not yet recruiting
Phase 2
Role of Homoeopathic medicines in treatment of children with worms.Health Condition 1: B770- Ascariasis with intestinal complicationsCTRI/2024/03/063707Raxitkumar Ramavat
Recruiting
Phase 2
Comparing 22 and 19G needles with EUS-FNB sampling for Cancer Gene Panel TestPancreatic massJPRN-jRCT1062210071Hironari Kato44
Not yet recruiting
Phase 3
How Calcarea carbonica 200c Homoeopathic Medicine works in Pain Management of Knee Joint in Osteoarthritis among Women aged 45-65 YearsCTRI/2023/02/049604Dr.Sailee Mysker
Completed
Not Applicable
Clinical trial for sacral pressure soreKCT0009002Dankook Univeristy Hospital38